Lewis & Clark Pharmaceuticals' Acquisition

Lewis & Clark Pharmaceuticals was acquired by Inspyr Therapeutics on May 31, 2017.

Lewis & Clark Pharmaceuticals is a biotechnology company developing novel proprietary compounds from a technology platform based on adenosine chemistry and biology.…

Articles about Lewis & Clark Pharmaceuticals' Acquisition: